Structure Therapeutics Inc.
NASDAQ:GPCR · NASDAQ Global Market
+$0.39 today
Vol 1.14M · Avg 0.87M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+101.40%
Period High
$93.79
Period Low
$16.20
Latest
$44.51
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Liquidia Corporation
NASDAQ:LQDA
$6.04B
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
$3.84B
uniQure N.V.
NASDAQ:QURE
$2.99B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.19B
Ocular Therapeutix, Inc.
NASDAQ:OCUL
$2.11B
Nuvation Bio Inc.
NYSE:NUVB
$1.89B
Galapagos N.V.
GLPG
$1.84B
Mesoblast Limited
NASDAQ:MESO
$1.84B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.65B
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$1.50B
What is the latest GPCR filing?
The latest filing shown is 424B5 dated May 7, 2026.
How many recent filings does GPCR have?
Intrinsic Alpha currently shows 20 recent filings for GPCR.
Explore More
Continue the stock analysis
Jump to another research area for this company.